Therapeutic Effect of Chang’an I Recipe (肠安 I 号方) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial
Xudong Tang(Xiyuan Hospital), Yin-qiang Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Lü(The Wistar Institute), Li-Na Meng(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Lü(Ningbo University), Wei Wei(Rutgers, The State University of New Jersey), Ping Wang(Feinstein Institute for Medical Research), Zhenhua Li(University of North Carolina at Chapel Hill), Fengyun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui Gao(Army Medical University), Zhipeng Tang(Shanghai University of Traditional Chinese Medicine), Baoshuang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying-pan Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Li-qun Bian(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 23
Related Papers
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
|Nature Biomedical Engineering|2022|258
NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival
|Molecular Biology of the Cell|2019|222
Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19
|Nature Nanotechnology|2021|170
Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury
|Critical Care|2015|129
Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis
|JCI Insight|2020|128